Jan. 27, 2017
Exosect Ltd. announced that it has increased the scope of its licence agreement with Talc USA for its patented Entostat® enabled fluency and dust reduction technology, to include the US market.
Talc USA launched the technology last year under the brand name Effusion® in Canada where the use of talc and graphite as fluency agents in seed treatments are banned for neonicotinoid treated corn and soybean seed. This ruling followed the conclusion from Health Canada’s Pest Management Regulatory Authority (PMRA) that ‘neonicotinoids present in dust generated during planting of treated corn and soybean seeds contributed to reported bee mortalities in 2012 and 2013.’ The current requirement by Canada’s PMRA is to use a dust-reducing fluency agent.
The novel electrostatic properties of the Entostat formulation platform employed in Effusion reduces dust by up to 97% as well as enables enhanced fluency, improved plantability and greater efficiency for seed treatment applications through reduced clumping and missed planting.
Talc USA is one of the largest talc suppliers for seed lubrication in the US. It also supplies inoculants and micronutrients to the seed using blended talc as the delivery system.
Steve Johnson, Owner of Talc USA comments, “We have been delighted with the performance of the product in Canada and we have received excellent feedback from the field. This product sits extremely well within our portfolio of seed planting technologies and we are delighted to be able to offer it to our US based customers.”
Exosect’s CEO, Andrew MacNaughton comments, “Talc USA are committed to bringing farmers new and innovative technology and we are delighted that they wish to expand the availability of this product.
Pressure on growers to deliver healthy crops while making minimal impact on the environment means that the focus on delivering crop protection and enhancement via the seed is ever increasing and we are delighted that Entostat is enabling greater sustainability for the seed treatment process.”